SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 43 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,394,000 | +44.9% | 1,232,394 | 0.0% | 0.82% | +59.4% |
| Q2 2022 | $5,102,000 | +8.9% | 1,232,394 | 0.0% | 0.51% | +59.0% |
| Q1 2022 | $4,683,000 | -15.6% | 1,232,394 | 0.0% | 0.32% | -3.6% |
| Q4 2021 | $5,546,000 | -3.4% | 1,232,394 | 0.0% | 0.33% | +29.5% |
| Q3 2021 | $5,743,000 | -33.9% | 1,232,394 | 0.0% | 0.26% | -31.4% |
| Q2 2021 | $8,688,000 | +19.3% | 1,232,394 | 0.0% | 0.38% | +46.9% |
| Q1 2021 | $7,283,000 | – | 1,232,394 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 20,711 | $81,000 | 0.89% |
| RA Capital Management | 4,681,858 | $18,212,000 | 0.33% |
| Ghost Tree Capital, LLC | 200,000 | $778,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $7,336,000 | 0.13% |
| Virtu Financial LLC | 39,062 | $152,000 | 0.03% |
| Quantitative Systematic Strategies LLC | 14,195 | $55,000 | 0.01% |
| Cetera Advisor Networks LLC | 85,000 | $331,000 | 0.01% |
| BAILARD, INC. | 38,600 | $150,000 | 0.01% |
| Chicago Partners Investment Group LLC | 14,081 | $52,000 | 0.01% |
| EXANE DERIVATIVES | 4,078 | $15,863,000 | 0.01% |